about
Cardiotoxicity in childhood cancer survivors: strategies for prevention and managementAn analysis of energy-drink toxicity in the National Poison Data System.Clinical research directions in pediatric cardiology.Cardiovascular disease in adult survivors of childhood cancer.The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats.Perinatal Factors Associated with Cardiovascular Disease Risk among Preschool-Age Children in the United States: An Analysis of 1999-2008 NHANES DataPotential latent effects of prenatal cocaine exposure on growth and the risk of cardiovascular and metabolic disease in childhoodCardiovascular effects in childhood cancer survivors treated with anthracyclines.Anthracycline-associated cardiotoxicity in survivors of childhood cancer.Health effects of energy drinks on children, adolescents, and young adults.Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort studyDiltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients.Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence.Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.HIV-related cardiovascular disease and drug interactions.Maternal calcium intake and offspring blood pressureChanges in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database.Cardiotoxicity of cancer chemotherapy: implications for children.Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis.Prenatal Cocaine Exposure and Cardiometabolic Disease Risk Factors in 18- to 20-Year-Old African Americans.Assessing latent effects of prenatal cocaine exposure on growth and risk of cardiometabolic disease in late adolescence: design and methods.Effectiveness of bariatric surgery in reducing weight and body mass index among Hispanic adolescents.The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity.Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors studyEpidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children.The Pediatric Cardiomyopathy Registry: 1995-2007.Ethnic group differences in cardiometabolic disease risk factors independent of body mass index among American youth.Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.Pediatric Cardiomyopathy as a Chronic Disease: A Perspective on Comprehensive Care Programs.Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus-Infected Individuals Treated With Highly Active Antiretroviral TherapyRisk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.Anthracycline associated cardiotoxicity in survivors of childhood cancer.Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.
P50
Q24628695-4056AA41-3EE7-44B6-A5C3-D62A744E8D82Q30656848-1D811F33-26F7-4F7E-9539-C402C0E78079Q33944043-6D5429C6-00A9-4764-945E-3DA459B76F9FQ34042984-7FD5786E-2D5F-41B2-BE46-87647F14429EQ34292469-C987543C-75CA-472B-A050-0EEABB426F71Q34299472-38A32DD1-6930-4CFA-AE61-FEE65535E227Q34566001-2926EDAB-8BDA-46E3-BAD3-4EA6F2A04BF2Q34572109-4FAB2A55-F3C9-427D-BB74-792545F40137Q34626238-852F3CD0-2E0A-410C-8A82-8DAD78865CCDQ34726274-2C97959F-4304-4568-B428-63E03275ED46Q34792830-F9B2C8B9-4288-4A3B-8AA7-54A2FF46A522Q35070184-2B4C4E4A-276B-4F73-9660-36D52A9B85B6Q35180758-435B4785-6B57-4346-80AD-3B0BA3074B28Q35429435-530B988A-FC00-4263-BAC6-77939E7ED991Q35562745-9B0F6C51-3E1E-4C65-87E9-35AB75250A14Q35732636-E4C14C81-1C73-4171-B64A-98EDDBDD1837Q35760873-1043A879-7DF8-49A0-873A-4BDE7A019B5BQ35902408-5C76F91B-0CD5-490A-91C9-DBB83DCE8813Q36008529-25775FD3-3612-4A97-BBB2-6DEA0ABC5BB3Q36157261-4B2A2670-CCC6-4CD3-B350-4C0FCDEA99A3Q36174517-E5CE6073-D20F-40F8-A490-4195F016F748Q36317218-F6402558-1D26-4455-AE68-B4236259ACCDQ36351474-B9B6C36B-243D-4F0F-B6B9-45A65A901E32Q36486427-7E69BA8D-7A4E-405B-9F2C-4F6A93C58A8DQ36511783-F184514B-CD4C-424A-8BDE-D086DD928EFFQ36590959-13C87554-EC9A-4920-921D-6D6070A59D6BQ36649653-5F68B85C-D256-4DEF-9C4A-2BD40421255CQ36674961-BD414103-99A9-45FC-8981-990E677A3B37Q36691172-44DD8160-5460-401D-8B07-6E1BDD917669Q36691178-2ABB9861-B069-42CF-89B4-3888CDE24696Q36778057-45E7B48E-B742-4AFA-B67F-0036838A158DQ36828128-583D0600-245A-4185-8BA0-CBA9F8ED175AQ36836082-CEFD5E60-517D-42AF-9FF7-486D1A6C5BA9Q36941650-46A20A48-DB8D-4420-883E-3D267AE24B6FQ36988601-94D83D9C-C13E-4396-A2E8-7FBD3C3FC5C3Q37016598-B0852C6F-AEEF-4434-B797-B5BF9D57BF31Q37062155-89910C0D-98F0-4AC1-91FB-57CBB672C8EFQ37078647-9BE82555-C492-41C0-A6F6-8963DE1CD82FQ37112428-AED986E3-8A0C-4B81-905A-8271A4C14E9DQ37126261-67159F7F-5041-4237-B193-0B44944E723F
P50
name
Steven E Lipshultz
@en
type
label
Steven E Lipshultz
@en
prefLabel
Steven E Lipshultz
@en